INCOG BioPharma Services Capacity Update October 2023: Biologics

INCOG BioPharma Services is a customer-driven CDMO launching a new standard for manufacturing life-saving injectable drugs. Leveraging 20+ years of past CDMO industry experience supporting manufacturing activities for over 200+ molecules and 50+ commercially approved therapeutics, INCOG BioPharma is a new standard CDMO with a purpose-built, state-of-art, 90,000 ft² facility designed for drug product fill-finish manufacturing. They are cGMP production-ready and support clinical through commercial manufacturing for biopharma companies. Currently INCOG has 40 million units of installed annual capacity to fill vials, syringes, or cartridges, with an expansion in 2024 that will take their capacity to over 140 million units annually. INCOG also offer services and support in Development, QC, Inspection/Labeling/Packaging, Device Assembly, Stability Studies, and Storage.